Cancer of Endometrium
13
2
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients
Tempus Priority Study: A Pan-tumor Observational Study
FitEx for Endometrial Cancer Survivors
Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients
Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma
The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma
Use of the Sentinel Node Biopsy for Early Endometrial Cancer.
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies